- Home
- ELMD vs CRBU Comparison
ELMD vs CRBU Comparison
Compare ELMD & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELMD | CRBU |
|---|---|---|
| Founded | 1992 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 208.1M | 166.6M |
| IPO Year | 2010 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELMD | CRBU |
|---|---|---|
| Price | $38.41 | $1.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $36.00 | $10.75 |
| AVG Volume (30 Days) | 127.8K | ★ 2.4M |
| Earning Date | 05-12-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.55 | 3.64 |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $54,716,000.00 | N/A |
| Revenue This Year | $15.59 | $1.63 |
| Revenue Next Year | $11.51 | $10.93 |
| P/E Ratio | $41.96 | ★ N/A |
| Revenue Growth | ★ 13.83 | N/A |
| 52 Week Low | $17.73 | $1.38 |
| 52 Week High | $47.40 | $3.53 |
Technical Indicators
Market Signals| Indicator | ELMD | CRBU |
|---|---|---|
| Relative Strength Index (RSI) | 40.66 | 35.14 |
| Support Level | $35.61 | $1.39 |
| Resistance Level | $40.00 | $1.73 |
| Average True Range (ATR) | 2.17 | 0.11 |
| MACD | -1.01 | -0.01 |
| Stochastic Oscillator | 9.48 | 0.94 |
Price Performance
Historical ComparisonAbout ELMD Electromed Inc.
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.